Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial
Not available.
Saved in:
Main Authors: | Sara Bringhen, Lorenzo Cani, Nicola Giuliani, Silvia Mangiacavalli, Giulia Benevolo, Elisabetta Antonioli, Renato Zambello, Roberto Ria, Iolanda Donatella Vincelli, Sonia Ronconi, Sonia More, Antonietta Pia Falcone, Alessandro Allegra, Mattia D'Agostino, Andrea Evangelista, Andrea Capra, Elisa Sciorsci, Paola Curci, Patrizia Tosi, Anna Marina Liberati, Anna Maria Cafro, Angelo Belotti, Francesca Patriarca, Donato Mannina, Katia Mancuso, Francesco Cattel, Giovannino Ciccone, Benedetto Bruno, Mario Boccadoro, Alessandra Larocca |
---|---|
Format: | Article |
Language: | English |
Published: |
Ferrata Storti Foundation
2025-07-01
|
Series: | Haematologica |
Online Access: | https://haematologica.org/article/view/12194 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study on the anaerobic biotreatment of prednisone wastewater
by: TU Zhan, et al.
Published: (2007-03-01) -
Bortezomib (velcade) plus melphalan and prednisone in elderly untreated patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01) -
Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
by: K. A. Belousov, et al.
Published: (2019-04-01) -
Comparing Prednisone and Methotrexate to Off-label Biologic Infliximab for Management of Ocular Uveitis: A Cost-minimization Analysis
by: William V. Padula, et al.
Published: (2015-01-01) -
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study
by: Frank Buttgereit, et al.
Published: (2019-06-01)